China Biologic Products Holdings Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2019 to a ratio of 17.68, above the company average. This is a clear sign of healthy business climate in the Biotechnology & Pharmaceuticals industry and improving liquidity at their respective customers, during the fourth quarter 2019. Average receivable collection period, for the China Biologic Products Holdings Inc in Dec 31 2019 quarter, has decreased to 21 days, compared to 28 days, in the 0 quarter.

If we take a look into Healthcare sector 409 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2019 from 0 to 3176.

What is Receivable Turnover Ratio?
What is China Biologic Products Holdings Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CBPO Receivables Turnover Ratio	(Dec 31 2019) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2018) IV. Quarter
Y / Y Receivable Change	-19.88 %	-	-	-	61.15 %
Y / Y Revenue Change	7.9 %	-	-	-	26.04 %
Receivable Turnover Ratio (TTM)	17.68	13.13	6.98	4.76	3.61
CBPO's Total Ranking	# 3176	# 0	# 3099	# 3173	# 3175
Accounts Receivable average collection period days	21	28	52	77	101
Seq. Receivable Change	-	-	-	-	13.69 %
Seq. Revenue Change	-	-	-	-	-

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 25
Healthcare Sector	# 410
Overall Market	# 3176

Receivable Turnover Ratio Statistics
High	Average	Low
0.61	0.52	0.23
(Jun 30 2015)		(Dec 31 2018)

CBPO Company Profile • Back to CBPO Efficiency Comparisons • Compare CBPO Receivables Turnover Ratio to its Competitors

Financial Statements
China Biologic Products Holdings Inc 's Accounts Receivable	$ 114 Millions	Visit CBPO's Balance sheet
China Biologic Products Holdings Inc 's Sales TTM	$ 504 Millions	Visit CBPO's Income Statement
Sources of CBPO's Revenues		Visit CBPO's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CBPO's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CBPO's Growth Rates	CBPO's Roa	CBPO's Inventory Turnover Ratio	CBPO's Dividend Comparisons
CBPO's Profitability Ratios	CBPO's Roi	CBPO's Asset Turnover Ratio	CBPO's Dividend Growth
CBPO's Valuation Ratios	CBPO's Roe	CBPO's Financial Strength Ratios	CBPO's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2019, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2019	Receivable at quarter ending Dec 31 2019
China Pharma Holdings Inc	12.12	$ 10.924 Millions	$ 0.902 Millions
Lifeloc Technologies Inc	12.11	$ 8.752 Millions	$ 0.723 Millions
Integrated Biopharma Inc	12.09	$ 53.275 Millions	$ 4.408 Millions
Momenta Pharmaceuticals inc	11.91	$ 23.868 Millions	$ 2.003 Millions
Myomo Inc	11.91	$ 3.838 Millions	$ 0.322 Millions
Geovax Labs Inc	11.86	$ 1.176 Millions	$ 0.099 Millions
Seres Therapeutics Inc	11.72	$ 34.505 Millions	$ 2.943 Millions
Precision Biosciences Inc	11.67	$ 22.238 Millions	$ 1.906 Millions
Acura Pharmaceuticals inc	11.46	$ 2.657 Millions	$ 0.232 Millions
Rockwell Medical inc	11.44	$ 61.303 Millions	$ 5.356 Millions
Tvardi Therapeutics Inc	11.43	$ 19.886 Millions	$ 1.740 Millions
Arvinas Inc	11.20	$ 42.976 Millions	$ 3.838 Millions
Ainos Inc	11.18	$ 0.012 Millions	$ 0.001 Millions
La Jolla Pharmaceutical Company	11.15	$ 23.054 Millions	$ 2.067 Millions
Travere Therapeutics Inc	11.14	$ 175.338 Millions	$ 15.745 Millions
Tivity Health Inc	11.06	$ 1,131.157 Millions	$ 102.260 Millions
Zynex inc	10.84	$ 45.472 Millions	$ 4.193 Millions
Surmodics Inc	10.81	$ 100.452 Millions	$ 9.296 Millions
Intellia Therapeutics Inc	10.78	$ 43.103 Millions	$ 4.000 Millions
Catalyst Pharmaceuticals Inc	10.70	$ 102.306 Millions	$ 9.565 Millions
Patterson Companies Inc	10.66	$ 5,640.256 Millions	$ 529.325 Millions
Exact Sciences Corporation	10.53	$ 876.293 Millions	$ 83.216 Millions
Fresenius Medical Care Ag	10.51	$ 19,573.742 Millions	$ 1,862.871 Millions
Nexgel Inc	10.47	$ 0.717 Millions	$ 0.069 Millions
Verastem Inc	10.46	$ 17.456 Millions	$ 1.669 Millions
Lexicon Pharmaceuticals Inc	10.44	$ 322.073 Millions	$ 30.836 Millions
Karyopharm Therapeutics Inc	10.36	$ 40.893 Millions	$ 3.948 Millions
Option Care Health Inc	10.27	$ 2,310.417 Millions	$ 224.906 Millions
National Healthcare Corp	10.24	$ 996.383 Millions	$ 97.270 Millions
Semler Scientific inc	10.24	$ 32.767 Millions	$ 3.200 Millions

Date modified: 2026-08-30T03:57:33+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.